NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

PhRMA gets defensive on eve of new “Dollars for Docs” report

A new edition of the ProPublica “Dollars for Docs” project she wrote:

“…biopharmaceutical companies are not just gatherers of clinical data, they are disseminators of that data, as well. After all, that information can’t help one patient if it doesn’t get to the physician first.”

Oh, this is going to be a fun exchange to follow.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Dr Joe

September 12, 2011 at 9:43 pm

Funny how the information does not need to get to physicians when the finding is negative about drugs.